Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia.
Maximilian StahlMichelle DeVeauxPau MontesinosRaphaël ItzyksonEllen K RitchieMikkael A SekeresJohn BarnardNikolai A PodoltsevAndrew BrunnerRami S KomrokjiVijaya R BhattAref A Al-KaliThomas CluzeauValeria SantiniGail J RobozPierre FenauxMark R LitzowAmir T FathiSarah PerreaultTae Kon KimThomas PrebetNorbert VeyVivek VermaUlrich GermingJuan BerguaJosefina SerranoSteven D GoreAmer M ZeidanPublished in: Leukemia & lymphoma (2018)